An MRI rating scale for amyloid-related imaging abnormalities with edema or effusion

American Journal of Neuroradiology

Volumn 34, Issue 8, 2013, Pages 1550-1555

  Barkhof, F ^a,b   Daams, M ^a   Scheltens, P ^b   Brashear, H R ^c   Arrighi, H M ^c   Bechten, A ^a   Morris, K ^c   McGovern, M ^c   Wattjes, M P ^a,b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JANSSEN RESEARCH AND DEVELOPMENT   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; BAPINEUZUMAB; PLACEBO;

AGED; BRAIN EDEMA; CLINICAL ARTICLE; CONFERENCE PAPER; CORRELATION COEFFICIENT; EFFUSION; FEMALE; HUMAN; IMAGE ANALYSIS; IMMUNIZATION; INTERRATER RELIABILITY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; RATING SCALE; VASCULAR AMYLOIDOSIS;

AGED; ALGORITHMS; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN EDEMA; CEREBRAL AMYLOID ANGIOPATHY; FEMALE; HUMANS; IMAGE ENHANCEMENT; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX; SUBDURAL EFFUSION;

EID: 84883056178     PISSN: 01956108     EISSN: 1936959X     Source Type: Journal    
DOI: 10.3174/ajnr.A3475     Document Type: Conference Paper

References (20)

1. McKhann G, Drachman D, Folstein M, et al. Clinical diagnosis of Alzheimer's disease: a report of the NINCDS-ADRDA work group under the auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-44
2. Selkoe DJ, Schenk D. Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics. Annu Rev Pharmacol Toxicol 2003;43:545-84
3. Schenk D, Barbour R, Dunn W, et al. Immunization with amyloidbeta attenuated Alzheimer-disease-like pathology in the PDAPP mouse. Nature 1999;400:173-77
4. Gilman S, Koller M, Black RS, et al. Clinical effects of A immunization (AN1792) in patients with AD in an interrupted trial. Neurology 2005;64:1553-62
5. Salloway S, Sperling R, Gilman S, et al. A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology 2009;73:2061-70
6. Ostrowitzki S, Deptula D, Thurfjell L, et al. Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab. Arch Neurol 2012;69:198-207
7. Weiner HL, Frenkel D. Immunology and immunotherapy of Alzheimer's disease. Nat Rev Immunol 2006;6:404-16
8. Rinne JO, Brooks DJ, Rossor MN, et al. 11C-PIB assessment of change in fibrillar amyloid-beta load in patients with Alzheimer's disease treated with bapineuzumab: a phase 2, double-blind, placebo- controlled, ascending dose study. Lancet Neurol 2010;9:363-72
9. Bayer AJ, Bullock R, Jones RW, et al. Evaluation of the safety and immunogenecity of synthetic Abeta42 (AN1792) in patients with AD. Neurology 2005;64:94-101
10. Sperling R, Salloway S, Brooks DJ, et al. Amyloid-related imaging abnormalities in patients with Alzheimer's disease treated with bapineuzumab: a retrospective analysis. Lancet Neurol 2012;11: 241-49
11. Nicoll JA, Wilkinson D, Holmes C, et al. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat Med 2003;9:448-52
12. Boche D, Zotova E, Weller RO, et al. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain 2008;131:3299-310
13. Black RS, Sperling RA, Safirstein B, et al. A single ascending dose study of bapineuzumab in patients with Alzheimer disease. Alzheimer Dis Assoc Disord 2010;24:198-203
14. Cordonnier C, van der Flier WM. Brain microbleeds and Alzheimer's disease: innocent observation or key player? Brain 2011;134:335-44
15. Greenberg SM, Vernooij MW, Cordonnier C, et al. Cerebral microbleeds: a guide to detection and interpretation. Lancet Neurol 2009;8:165-74
16. Sperling RA, Jack CR, Black SE, et al. Amyloid-related abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Round Table Workgroup. Alzheimers Dement 2011;7:367-85
17. Gregoire SM, Chaudhary UJ, Brown MM, et al. The Microbleed Anatomical Rating Scale (MARS): reliability of a tool to map brain microbleeds. Neurology 2009;73:1759-66
18. Wahlund LO, Barkhof F, Fazekas F, et al. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke 2001;32:1318-22
19. McGraw KO, Wong SP. Forming inferences about some intraclass correlation coefficients. Psychological Methods 1996;1:30-46
20. Bartko JJ. The intraclass correlation coefficient as a measure of reliability. Psychological Reports 1966;19:3-11